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Abstract 
Rapid production of neutralizing antibody can be critical for limiting the spread of infection. 
Such early antibody results when B blasts mature directly to plasmablasts without forming 
germinal centres. These extrafollicular responses can involve Ig class switch recombination 
(CSR) producing antibody that can readily disseminate through infected tissues. The present 
study identifies the differentiation stage where CSR occurs in an extrafollicular response 
induced by (4-hydroxy-3-nitrophenyl acetyl) (NP) conjugated to Ficoll. To do this we took 
advantage of the antigen dose dependency of CSR in this response. Thus, while both 30 g 
and 1 g NP-Ficoll induced plasmablasts, only the higher antigen dose induces CSR. 
Activation-induced cytidine deaminase (AID) is critical for CSR and in keeping with this a 
proportion of NP-specific B blasts induced by 30 g NP-Ficoll express AID. None of the B 
blasts responding to the non-CSR-inducing 1 g dose of NP-Ficoll express AID. We 
confirmed that CSR occurs in B blasts by demonstrating the presence of rearranged heavy 
chain transcripts in B blasts in the 30 g response. CSR in this extrafollicular response is 
confined to B blasts, for NP-specific plasmablasts, identified by expressing CD138 and 
Blimp1, no longer express AID and cannot undergo CSR. 
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Introduction 
The rapid induction of neutralizing antibody can be a critical factor in limiting the spread of 
the extracellular infection [1-3]. This is achieved by direct antigen-driven differentiation of B 
cells into B blasts and then plasmablasts and plasma cells without going through an affinity 
maturation stage in germinal centres [4-6]. For this reason the rapid route to antibody 
production is commonly referred to as extrafollicular responses, and these lead to the 
production of non-switched and switched antibodies. While the induction of CSR seems to 
happen at the follicle – T zone interphase [6], the earliest class switched B cells have been 
observed in follicles [7]. The object of the present study is to identify differentiation stages 
during extrafollicular antibody responses when CSR occurs, and whether these relate to GC 
or plasmablast differentiation. To do this we have studied B cells responding in vivo to the 
thymus-independent type 2 (TI-2) antigen – NP-Ficoll. The characterization of cells at the 
single cell level early in the response has been facilitated by the use of F1 hybrids of 
quasimonoclonal (QM) and C57BL/6 mice (QMxB6 mice). These hybrids have one copy of a 
targeted insertion of a rearranged NP-specific Ig heavy chain [8]. The 5 percent of B cells 
that have a productive lambda light chain rearrangement in these mice are specific for NP [9].  
NP-Ficoll induces an impressive extra-follicular antibody response in QMxB6 mice. In 
addition, at high antigen doses it can induce (GC) [10]. These, however, are abortive, for the 
GC B cells enter apoptosis at the stage when their continued survival depends on antigen-
specific selection by T cells. In this study we use a combination of flow cytometry with 
single cell sorting and real-time RT-PCR to identify responding B blasts from plasmablasts 
and GC founding cells. Differentiation of B blasts towards plasmablasts or GC B cells is 
tightly regulated by a network of transcription factors. We used the expression of three of 
these to distinguish B blasts, plasmablasts and GC founding cells. The main transcription 
factor associated with confirmed differentiation towards the plasmablast phenotype is 
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Blimp1, encoded by the gene Prdm1 [11]. Blimp1 in combination with surface expression of 
CD138 is used to identify plasmablasts. The master regulator of GC B cell commitment is 
Bcl6. Bcl6 and Blimp1 mutually repress each other [12-14]. The co-expression of AID with 
Bcl6 is used to identify GC founding cells. As mentioned above AID is essential for CSR and 
in GC is required for Ig V-region hypermutation [15]. It is well documented that CSR occurs 
in GC [16]. The question addressed below is whether AID is expressed in B blasts or 
plasmablasts or both of these cell types as they develop along the extrafollicular pathway, and 
whether this expression is associated with CSR. 
Results and Discussion 
CSR occurs in B blasts rather than plasmablasts responding to NP-Ficoll  
To identify where and when CSR occurs in the response to NP-Ficoll it is necessary to 
summarize the pattern of migration and differentiation of NP-specific B cells in responses to 
NP-Ficoll. As in wild type mice [17] NP-specific cells from QMxB6 mice move from the 
marginal zone and follicles to the T zone within 8h of immunization with 30 g NP-Ficoll 
(Fig 1A top two panels). The responding cells enter cell cycle by 24h after immunization (not 
shown). By 48h post immunization proliferation has increased the number of NP-specific 
cells (Fig 1B top) and B blasts are spread throughout the white pulp (Fig. 1A lower left). The 
white arrowheads in this photomicrograph identify the first CD138
+
 plasmablasts, which have 
appeared where the red pulp abuts to the T zone. This is reflected by an increase in 
NP
+
CD138
+
 cells seen by flow cytometry (Fig 1B bottom). By 72h large accumulations of 
CD138
+
 plasmablasts fill the red pulp, although there are still many B blasts in the white pulp 
(Fig 1A centre bottom panel). Clusters of Bcl6
+
 NP-specific GC-founding B blasts first 
appear in the centre of follicles at 72h, while Bcl6 expression is not seen prior to 
immunization or in non-responding naive B cells (Fig 1A bottom right). Quantitative 
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immunohistology shows that by 72h a significant proportion of the plasmablasts have 
switched to IgG3 (Fig 1D left panel).  
To determine whether CSR induced by 30 g NP-Ficoll takes place in the B blasts, or 
plasmablasts, or both of these cell types, responding B cells were sorted by flow cytometry 
(Fig 1C). NP-specific B cells were identified as B220
+
 cells that bind NP-conjugated to 
phycoerythrin (PE). At 24h after immunization NP-PE binding by NP-specific cells is 
markedly reduced, probably due to competition for BCR ligation with the immunogen and/or 
BCR internalization. To detect NP-specific cells at this time point mice were immunized with 
NP-FITC-Ficoll and FITC-positive cells were sorted (cells shown in red in Fig. 1B inset). 
The expression of CD138 (blue gate) was used to distinguish plasmablasts from B blasts (red 
gate, which includes GC founding cells). 
Bulk sorts of NP-specific cells at 24h intervals post immunization were analyzed to identify 
the appearance of heavy chain transcripts containing Iapposed to IgG3 heavy chain genes 
(Fig 1D centre panel). These rearranged heavy chain transcripts can only be expressed in 
cells that have completed CSR to IgG3 [18], and are a good indicator of the frequency of 
class switched cells, as the I exon is constitutively active [19]. There is a significant 
accumulation of the I-3 transcripts in the B blast population sorted at 48h. Both the 
plasmablast and B blast populations have higher levels of these transcripts at 72h (Fig 1D 
centre).  
These observations indicate that CSR does occur in B blasts in this response but not if this 
process continues in plasmablasts. To probe this, the same bulk sorts were tested for the 
expression of Aicda transcripts. This shows that some cells in the B blast fractions at 48h and 
72h express AID, while the plasmablast fraction does not (Fig 1D right panel). At this time 
UNG mRNA has also been induced (suppl. Fig. 1), but blasts still express Pax5 mRNA, the 
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main transcription factor associated with B cell phenotype, and do not express XBP1 mRNA, 
which drives Ig secretion in plasma cells (suppl. Fig 1) These results show that by the time 
cells responding to NP-Ficoll express CD138 they have lost the capacity to initiate further 
CSR. At 48h after immunization B blasts are found in all compartments of the white pulp. 
Class switched B blasts, as opposed to GC blasts, have also been identified in follicles and T 
zones at the early stages of T dependent responses [7, 20]. The precise features of the 
microenvironments within the white pulp where CSR occurs in B blasts remains to be 
determined. 
Single cell analysis confirms that a proportion of extrafollicular B blasts and GC 
founding B blasts express AID while plasmablasts do not 
To determine the proportion of B blasts that express AID transcripts and whether these have 
transcriptional regulation similar to emerging extrafollicular plasmablasts or GC founding 
cells, multiplex real time RT-PCR was carried out on single cells. The left hand set of graphs 
in Fig 2 show representative individual experiments in which single NP-specific cells were 
sorted into the wells of 384-well plates. They were then assessed for expression of mRNA for 
AID with Bcl6, or AID with Blimp1. To exclude empty wells, each well was assessed for the 
constitutively-expressed 2microglobulin - as outlined in the methods. The right hand set of 
graphs shows a summary of the single cell RT-PCR results from all the individual 
experiments.  
Neither AID nor Blimp-1 was expressed in NP-PE-binding B220
+
 cells before immunization 
(Fig 2 B, C right side). By contrast some 40% of these cells express Bcl-6 message (Fig 2 A). 
Despite presence of Bcl-6 mRNA, naïve B cells express little or no Bcl-6 protein at levels 
detectable by immunoenzymatic staining (Fig.1A and [21]). Bcl-6 mRNA is progressively 
lost following immunization (Fig. 2A), and is only re-expressed in germinal centre founding 
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cells 72h after immunization (Fig. 2D). The appearance of cells coexpressing Bcl-6 and AID 
mRNA at high levels (median 10x higher) coincides with the appearance of clusters of NP-
specific cells in follicle centres that express Bcl6 protein, as shown by immunohistology (Fig 
1A bottom right).  
Fig 2B confirms that AID is induced in B blasts. AID mRNA is first found in B blasts 48h 
post NP-Ficoll. At this stage, when no AID
+
/Bcl-6
+
 coexpressing GC founding cells are 
present (Fig 2 D right), AID mRNA is expressed in the absence of Bcl6 mRNA in around 
10% of B blasts. Cells with this phenotype are still present at 72h (Fig. 2B right). In striking 
contrast CD138
+
 NP-binding cells do not express AID. This even applies to the small number 
of early plasmablasts that are present at 48h after immunization. At this stage a median of 
80% of the CD138
+
 cells express Blimp-1 mRNA while >95% of these cells express Blimp-1 
at 72h. The presence of a significant minority of CD138
+
 cells that do not express Blimp-1 
raises the question whether this regulator of plasmablast differentiation is the sole repressor 
of AID. Out of 683 cells studied in total only 3 showed co-expression of Bcl6 and Blimp1. 
The antigen-dose-dependency of AID-induction and switching induced by NP-Ficoll  
We have previously reported that higher doses of NP-Ficoll are required to induce the NP-
specific B cells of QM mice to produce GC than are needed to induce the production of extra-
follicular plasmablasts [10]. Serendipitously, on reviewing this earlier study we identified an 
effect of antigen dose on CSR. While 1 g of NP-Ficoll is sufficient to induce a significant 
number of NP-specific B blasts to mature into plasmablasts (Fig 3A and suppl. Fig 2) it does 
not induce CSR (Fig 3D). The expression of the proliferation marker Ki-67 distinguishes the 
plasmablasts induced by 1 g NP-Ficoll from the background plasma cells seen in QMxB6 
mice, which typically are not proliferating (Fig 3A and C). NP-binding plasmablasts and B 
blasts were sorted from mice 48h after immunizing with 1 g or 30 g of NP-Ficoll and the 
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expression of AID message was again assessed by single cell real time RT-PCR (Fig 3E). 
AID was expressed by a proportion of the B blasts from mice immunized with 30 g of NP-
Ficoll, but was not expressed in any cells from mice immunized with 1 g of NP-Ficoll, 
confirming that early expression of AID is related to CSR in extrafollicular B differentiation. 
Concluding remarks 
Although CSR is associated with B cell proliferation and differentiation in germinal centres 
[22, 23], CSR is also induced during extrafollicular plasmablast differentiation. During the 
initial response to T dependent antigens [6], and in responses to TI-2 antigens it is the only 
pathway of productive B cell differentiation and CSR [17]. We show here that AID induced 
by NP-Ficoll is expressed at lower levels than in GC blasts and is not coexpressed with Bcl6. 
Germinal centre independent class switching may represent an ancient pathway of AID 
induction that developed before proper germinal centres evolved, as is seen in lower 
vertebrates that develop plasma cells and undergo CSR in the absence of germinal centres 
[24]. CSR occurring before affinity maturation happens may seem counterproductive, as a 
switch from IgM to IgG leads to a loss of avidity of the resulting antibody. On the other hand, 
infections often induce efficient extrafollicular plasmablast differentiation, while germinal 
centre development is delayed. The gain of additional effector function from switched 
immunoglobulin may be critical in providing early protective immunity from life threatening 
infections [25].  
Material and methods 
Animals and immunizations 
QM mice [8] (backcrossed to C57BL/6J for >10 generations) were bred under specific 
pathogen free conditions in the Biomedical Services Unit, University of Birmingham. 
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QMxB6 mice were generated by crossing mice homozygous for the NP-specific (VH17.2.25-
DSP2.3-JH4) Ig heavy chain segment of QM mice and light chain deficient with C57BL/6 
mice to generate mice with one copy of the NP-specific QM IgH and  light chain genes. 
Animal experiments were licensed by the British Home Office according to the Animals 
Scientific Procedures Act 1986 and approved by the University of Birmingham Biomedical 
Ethical Review Subcommittee. 
Immunizations 
Mice were immunized i.p. with either 30 g or 1 g NP40-Ficoll or, when 24h time points 
were taken, 30 g NP-fluorescein-Ficoll (Biosearch Technologies, Novato, CA).  
Antigen-specific B cell staining and isolation  
Location of antigen-specific idiotype-positive B cells in frozen spleen sections was detected 
by immunohistology as described previously [6]. Briefly, acetone-fixed frozen spleen 
sections (6 μm) were stained using rat anti mouse CD3, IgM, IgD or CD138 (BD 
Biosciences, Oxford, UK), rat anti mouse IgG3 (Serotec, Oxford, UK), sheep anti mouse IgD 
(The Binding site, Birmingham, UK), rabbit-anti mouse Bcl6 1/30 (Santa Cruz 
Biotechnology, CA), or NP conjugated to rabbit Ig. Secondary antibodies conjugated to 
biotin or horseradish peroxidase were applied. The biotinylated secondary antibodies were 
detected using biotin conjugated StreptABComplex-alkaline phosphatase complex (Dako, 
Ely, UK).  
Immunostaining of single-cell splenocyte suspensions following immunization with NP-
Ficoll used B220-FITC (eBioscience), CD138-APC or CD138-biotin, followed by 
streptavidin-PerCpCy5.5 or streptavidin-APC (BD Biosciences), and NP-phycoerythrin 
(Biosearch Technologies). Antigen-specific B cells 24h after immunization with NP-FITC-
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Ficoll were identified by their FITC uptake and NP-phycoerythrin plus B220-APC staining. 
Cell sorting was carried out on a MoFlo cell sorter (DakoCytomation). Sorted populations 
were checked for purity and frozen at -80ºC immediately after sorting. 
Real time RT-PCR 
RNA was extracted from frozen cell pellets. I-C3 transcript was detected by real-time RT-
PCR with primers TCTGGACCTCTCCGAAACCA and ACCGAGGATCCAGATGTGTCA 
together with the FAM-BHQ labelled probe CTGTCTATCCCTTGGTCCCTGGCTGC 
(Eurogentec, Southampton, UK) in multiplex with -actin specific primers as described [25]. 
AID, Pax5, UNG and XBP1 were detected using TaqMan gene expression assays 
Mm00507774_m1, Mm00435501_m1, Mm00449156_m1 and Mm00457359_m1 (Applied 
Biosystems, Foster City, CA).  
Single cell RT-PCR 
Single cells were sorted into wells, containing 1 l nuclease-free water, of 384-well PCR 
plates using an automatic cell cloning unit of a MoFlo cell sorter. Serial dilutions of 0 to 32 
cells per well served as positive and one row without cells as negative controls. After sorting 
plates were stored frozen at -80ºC. Triplex real-time RT-PCR used primers in limiting 
concentrations with QuantiTect Multiplex RT-PCR buffer (Qiagen, Crawley, UK) in a final 
volume of 6 l. The following primers and probes were used: β2-microglobulin 
(CTGCAGAGTTAAGCATGCCAGTAT 100 nM, ATCACATGTCTCGATCCCAGTAGA 
100 nM, NED-CGAGCCCAAGACC-MGB, Applied Biosystems). Blimp1 
(CAAGAATGCCAACAGGAAGTATTTT 80nM, CCATCAATGAAGTGGTGGAACTC 
100 nM, FAM-TCTCTGGAATAGATCCGCCA-MGB, Applied Biosystems), Aicda 
(GTCCGGCTAACCAGACAACTTC 60 nM, GCTTTCAAAATCCCAACATACGA 100 
nM, TET-TGCATCTCGCAAGTCATCGACTTCGT-BHQ1, Eurogentec). Bcl6 was detected 
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with primers (CAGACGCACAGTGACAAACCA, 60 nM, 
ACTGCGCTCCACAAATGTTACA 300 nM) and probe FAM-
CAGCCACAAGACTGTCCACACGGGT-BHQ1 (Eurogentec) in multiplex with Aicda, or 
CalFluor560-CAGCCACAAGACTGTCCACACGGGT-BHQ1 (BioSearch Technologies) in 
multiplex with Blimp1. Reactions were run for 40 cycles in a 7900 Real-Time PCR System 
(Applied Biosystems). Data from wells that were positive for 2microglobulin mRNA were 
plotted as cycle number at which target gene was higher than threshold (Ct) in reverse order, 
which corresponds to mRNA quantity per cell on a log2 scale. Preliminary experiments 
showed that this setup produced semi-quantitative results with good negative correlation 
between Ct and log2 of the amount of template mRNA (suppl. Fig. 3). 
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Legends to figures: 
Figure 1: The emergence of plasmablasts, GC founding cells and Ig class switching.  
QMxB6 mice were immunized i.p. with 30 μg NP-Ficoll.  A) The location and differentiation 
of NP-specific B cells are shown by immunohistology. Before immunization (top left, 0h) 
NP-binding B cells (blue) are located mainly in marginal zone (MZ) and follicles (F). 
Follicles are identified by the presence of IgD
+
 B cells (brown). By 8h (top right) the NP-
specific B cells are located in the outer T zone (T). At 48h (bottom left) NP-binding cells fill 
the white pulp and arrow heads indicate small numbers of darker-staining plasmablasts at the 
red pulp (RP)-T zone junction. At 72h CD138
+
 red pulp plasmablasts (PB) stained for CD138 
(blue) crowd the red pulp (bottom centre) and clusters of Bcl6
+
 germinal centre founding 
cells fill the follicle centres (bottom right). B) Total numbers of NP-binding cells and the 
numbers of CD138
+
NP-binding plasmablasts and plasma cells, determined by flow 
cytometry. C) Flow cytometric sorting of NP-binding B cells responding to NP-Ficoll. Some 
5% of C57B6xQM mouse B cells are NP-specific pre immunization (left); 24h after 
immunization B cells bind NP-phycoerythrin less efficiently (middle left), and are detected 
via NP-FITC-Ficoll staining used as immunogen (red, inset); 72h after immunization NP-
binding B cells are divided into two fractions (right): CD138
–
 B220
+
 and CD138
+
.  D) 
Increase in the number of IgG3 expressing cells, assessed by immunohistochemistry (left). 
The relative amounts of recombined Iμ-Cγ3 heavy chain transcripts (centre) or Aicda mRNA 
(right) assessed by real-time RT-PCR in NP-binding cells sorted using the gates shown in B. 
Each diamond represents the data from the sorted cells from one mouse. The colours or the 
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diamonds correspond to the colours of the gates in (C). Statistics indicate Mann Whitney U 
test results. 
Figure 2: Transcriptional differentiation of B blasts, plasmablasts, and GC founding cells  
Single NP-binding cells from the spleens of QMxB6 mice immunized with 30 μg NP-Ficoll 
were FACS sorted into the wells of 384-well plates using the gates shown in Figure 1C. The 
mRNA levels for AID and Bcl6, or AID and Blimp1 in each cell were determined by real 
time RT-PCR. Left hand column of figures shows the level of indicated mRNAs in individual 
cells in a single experiment (each diamond corresponds to one cell). Numbers on the 
horizontal and vertical axes represent the PCR cycle when signal above threshold was 
reached (Ct), corresponding to a log2 scale of mRNA quantity per cell. Percentages indicate 
the proportion of cells in each quadrant. The right hand column of figures shows the 
percentages of cells expressing the indicated mRNAs over time in the different FACS-sorted 
cell populations, with each diamond representing one experiment.  
Figure 3: The antigen-dose-dependency of AID-induction and switching induced by NP-Ficoll   
QMxB6 mice were immunized i.p. with either 30 g or 1 g of NP-Ficoll A) The induction 
of NP-specific plasmablasts (blue) in the red pulp of mice by 1 μg NP-Ficoll. Left is before 
immunization, right taken 96h after immunization. Red boxes show magnifications of the 
same clusters of plasma cells or plasmablasts in serial sections stained for the proliferation-
associated marker - Ki-76 (brown) NP-binding (blue). B) Flow cytometric quantification of 
numbers of CD138
+
 NP-binding cells in the spleen of mice immunized 72h after 
immunization with 1 g or 30 g NP-Ficoll. C) The proportion of NP-specific plasmablasts 
that are Ki-67
+
 before seen on spleen sections 96h after immunization with 1 g NP-Ficoll (+ 
SD). D) Assessment of the numbers of plasmablasts switched to IgG3 in sections of spleen 
taken 96h after immunizing with 1g or 30 g. E) The proportion of NP-binding cells from 
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the spleens of QMxB6 mice 48h after immunization with1 g or 30 g NP-Ficoll that express 
mRNA for Blimp1, or Bcl6, or AID without Bcl6 assessed by single cell real time RT-PCR. 
 
